Differential effect of molecular size HA in mouse chondrocytes stimulated with PMA

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 10, 2009, Pages 1353-1367

  Campo, Giuseppe M ^a   Avenoso, Angela ^a   Campo, Salvatore ^a   D'Ascola, Angela ^a   Traina, Paola ^a   Calatroni, Alberto ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

CD44; Chondrocytes; Hyaluronan; Inflammation; Interleukins; PMA

Indexed keywords

COLLAGENASE 3; HERMES ANTIGEN; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL STIMULATION; CONTROLLED STUDY; ENZYME ASSAY; GENE EXPRESSION; INFLAMMATION; MOLECULAR SIZE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD44; BLOTTING, WESTERN; CELLS, CULTURED; CHONDROCYTES; DOSE-RESPONSE RELATIONSHIP, DRUG; HYALURONIC ACID; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 13; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN KINASE C-DELTA; PROTEIN KINASE C-EPSILON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70049104174     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.07.003     Document Type: Article

References (47)

1. Burgess J.K. The role of the extracellular matrix and specific growth factors in the regulation of inflammation and remodelling in asthma. Pharmacol. Ther. 122 (2009) 19-29
2. D.J. Kaczorowski, K.P. Mollen, R. Edmonds, T.R. Billiar, Early events in the recognition of danger signals after tissue injury, J. Leukoc. Biol. 83 (2008) 546-552.
3. Fraser J.R., Laurent T.C., and Laurent U.B. Hyaluronan: its nature, distribution, function and turnover. J. Intern. Med. 242 (1997) 27-33
4. Noble P.W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 21 (2002) 25-29
5. Almond A. Hyaluronan. Cell. Mol. Life Sci. 64 (2007) 1591-1596
6. Adair-Kirk T.L., and Senior R.M. Fragments of extracellular matrix as mediators of inflammation. Int. J. Biochem. Cell Biol. 40 (2008) 1101-1110
7. Jiang D., Liang J., and Noble P.W. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 23 (2007) 435-461
8. Yamawaki H., Hirohata S., Miyoshi T., Takahashi K., Ogawa H., Shinohata R., Demircan K., Kusachi S., Yamamoto K., and Ninomiya Y. Hyaluronan receptors involved in cytokine induction in monocytes. Glycobiology 19 (2009) 83-92
9. Wang C.T., Lin Y.T., Lin B.L.Y.H., and Hou S.M. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthr. Cartil. 14 (2006) 1237-1247
10. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., and Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 61 (1990) 1303-1313
11. Heldin P., Karousou E., Bernert B., Porsch H., Nishitsuka K., and Skandalis S.S. Importance of hyaluronan-CD44 interactions in inflammation and tumorigenesis. Connect. Tissue Res. 49 (2008) 215-218
12. Yoshizaki A., Iwata Y., Komura K., Hara T., Ogawa F., Muroi E., Takenaka M., Shimizu K., Hasegawa M., Fujimoto M., and Sato S. Clinical significance of serum hyaluronan levels in systemic sclerosis: association with disease severity. J. Rheumatol. 35 (2008) 1825-1829
13. Hanz Z., Lin G.J., Chi F.L., Wang S.Y., Huang J.M., Liu H.J., and Zhang L.R. The relationship between the extracellular matrix and the angiogenesis and metastasis of laryngeal carcinoma. ORL J. Otorhinolaryngol. Relat. Spec. 70 (2008) 352-358
14. Chen H.C., Shah S.H., Li Y.J., Stabler T.V., Jordan J.M., and Kraus V.B. Inverse association of general joint hypermobility with hand and knee osteoarthritis and serum cartilage oligomeric matrix protein levels. Arthritis Rheum. 58 (2008) 3854-3864
15. Nobili V., Parkes J., Bottazzo G., Marcellini M., Cross R., Newman D., Vizzutti F., Pinzani M., and Rosenberg W.M. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology 136 (2009) 160-167
16. Weiss L., Slavin S., Reich S., Cohen P., Shuster S., Stern R., Kaganovsky E., Okon E., Rubinstein A.M., and Naor D. Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 285-290
17. Zoller M., Gupta P., Marhaba R., Vitacolonna M., and Freyschmidt-Paul P. Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases. J. Leukoc. Biol. 82 (2007) 57-71
18. Hutas G., Bajnok E., Gal I., Finnegan A., Glant T.T., and Mikecz K. CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocytes recruitment in experimental arthritis. Blood 112 (2008) 4999-5006
19. Baier G., and Wagner J. PKC inhibitors: potential in T cell-dependent immune diseases. Curr. Opin. Cell. Biol. 21 (2009) 262-267
20. Thorne R.F., Legg J.W., and Isacke C.M. The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events. J. Cell. Sci. 117 (2004) 373-380
21. Larsson C. Protein kinase C and the regulation of the actin cytoskeleton. Cell. Signal. 18 (2006) 276-284
22. Okamoto I., Kawano Y., Matsumoto M., Suga M., Kaibuchi K., Andò M., and Saya H. Regulated CD44 cleavage under the control of protein kinase C, calcium influx, and the Rho family of small G proteins. J. Biol. Chem. 274 (1999) 25525-25534
23. Liu D., Liu T., Li R., and Sy M.S. Mechanisms regulating the binding activity of CD44 to hyaluronic acid. Front. Biosci. 3 (1998) d631-d636
24. Fitzgerald K.A., Bowie A.G., Skeffington B.S., and O'Neill L.A.J. Ras, protein kinase Czeta and IkB kinase 1 and 2 are downstream effectors of CD44 during the activation of NF.kB by hyaluronic acid fragments in T-24 carcinoma cells. J. Immunol. 164 (2000) 2053-2063
25. Kumar A., Takada Y., Boriek A.M., and Aggarwal B.B. Nuclear factor-kappaB: its role in health and disease. J. Mol. Med. 82 (2004) 434-448
26. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
27. Naor D., Nedvetzki S., Walmsley M., A Yayon E.A., Turley I., Golan D., Caspi L.E., Sebban Y., Zick T., Garin D., Karussis N., Assayag-Asherie I., Raz L., Weiss S., and Slavin I. Golan, CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice. Ann. N.Y. Acad. Sci. 1110 (2007) 233-247
28. Naor D., and Nedvetzki S. CD44 in rheumatoid arthritis. Arthritis Res. Ther. 5 (2003) 105-115
29. Newton A.C. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem. J. 370 part2 (2003) 361-371
30. Martelli A.M., Evangelisti C., Nyakern M., and Manzoli F.A. Nuclear protein kinase C. Biochim. Biophys. Acta 1761 (2006) 542-551
31. Newton A.C. Lipid activation of protein kinases. J. Lipid Res. 50 Suppl (2009) S266-S271
32. Griner E.M., and Kazanietz M.G. Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer 7 (2007) 281-294
33. McKee C.M., Penno M.B., Cowman M., Burdick M.D., Strieter R.M., Bao C., and Noble P.W. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. J. Clin. Invest. 98 (1996) 1403-1413
34. McKee C.M., Lowenstein C.J., Horton M.R., Wu J., Bao C., Chin B.Y., Choi A.M.K., and Nobles P.W. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kB-dependent mechanism. J. Biol. Chem. 272 (1997) 8013-8018
35. Mun S.H., Kim J.W., Nah S.S., Co N.Y., Lee J.H., Kim J.D., Kim H.S., Choi J.D., Kim S.H., Lee C.K., Park S.H., Kim B.K., Kim H.S., Kim Y.M., and Choi W.S. Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the syk/protein kinase Cdelta/JNK pathway in rheumatoid synovial fibroblasts. Arthritis Rheum. 60 (2009) 678-685
36. Chen L.Y., Doerner A., Lehmann P.F., Huang S., Zhong G., and Pan Z.K. A novel protein kinase C (PKCepsilon) is required for fMet-Leu-Phe-induced activation of NF-kappaB in human peripheral blood monocytes. J. Biol. Chem. 280 (2005) 22497-22501
37. Lamontagne C.A., and Grandbois M. PKC-induced stiffening of hyaluronan/CD44 linkage; local force measurements on glioma cells. Exp. Cell Res. 314 (2008) 227-236
38. Yates E.A., Terry C.J., Rees C., Rudd T.R., Duchesne L., Skidmore M.A., Lèvy R., Thanh N.T., Nichols R.J., Clarke D.T., and Fernig D.G. Protein-GAG interactions: new surface-based techniques, spectroscopies and nanotechnology probes. Biochem. Soc. Trans. 34 (2006) 427-430
39. Steeber D.A., Venturi G.M., and Tedder T.F. A new twist to the leukocyte adhesion cascade: intimate cooperation is key. Trends Immunol. 26 (2005) 9-12
40. Eberlein M., Scheibner K.A., Black K.E., Collins S.L., Chan-Li Y., Powell J.D., and Horton M.R. Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression. J. Inflamm. 5 (2008) 5-20
41. Lohr M., Kummel F., Martus P., Cidlinsky K., Kroger J.C., Hahn E.G., Oesterling C., Emmrich J., Schuppan D., and Liebe S. Serum levels of extracellular matrix in acute pancreatitis. Hepatogastroenterology 46 (1999) 3263
42. Sasamura H., Kitamura Y., Nakamura M., Ryuzaki M., and Saruta T. Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertension. Clin. Exp. Hypertens. 28 (2006) 511
43. Kong S.Y., Stabler T.V., Criscione L.G., Elliott A.L., Jordan J.M., and Kraus V.B. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis Rheum. 54 (2006) 2496
44. Farkkila M., Rautiainen H., Karkkainen P., Karvonen A.L., Nurmi H., and Niemela O. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy. Liver Int. 28 (2008) 787
45. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur. J. Cell. Biol. 83 (2004) 317-325
46. Presti D., and Scott J.E. Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH.) radicals is dependent on hyaluronan molecular mass. Cell. Biochem. Funct. 12 (1994) 281-288
47. Campo G.M., Avenoso A., Campo S., D'Ascola A., Traina P., Samà D., and Calatroni A. The antioxidant effect exerted by TGF-1beta-stimulated hyaluronan production reduced NF-kB activation and apoptosis in human fibroblasts exposed to FeSo4 plus ascorbate. Mol. Cell. Biochem. 311 (2008) 167-177